PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA

CANNANNEW REPORT

OXFORD, Ohio and COCONUT CREEK, Fla., April 26, 2021 /CNW/ — PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company“), a… Read More…..

Excerpt only …
READ MORE BELOW
Source : PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.